Expert Interviews

March 02, 2021

Published in late February, results of the STEP 1 and STEP 3 trial give clinicians insight into the effects of 2.4 mg subcutaneous semaglutide as an intervention for weight loss in overweight or obese patients ahead of a potential approval in June 2021.

December 21, 2020

Experts in diabetes provide their perspective on various facets of diabetes management including the use of insulin pumps.

December 14, 2020

Learn why one organization prioritizes screening for diabetic retinopathy among patients with diabetes.

December 14, 2020

A discussion centered around optimizing the number of patients with diabetes who receive screening for diabetic retinopathy to ensure the best quality outcomes.

November 27, 2020

Jeffrey Curtis, MD, MS, MPH, details how the perception of biphosphonates has been detrimental to efforts to improve treatment and diagnosis of osteoporosis.

November 24, 2020

An endocrinologist from Brigham and Women’s Hospital discusses the latest in diabetes management.

November 24, 2020

Jeffrey Curtis, MD, MS, MPH, offers his thoughts on the most effective methods to address the underdiagnosis and undertreatment of osteoporosis in older male patients.

November 18, 2020

A cardiologist from Brigham and Women's Hospital offers his thoughts on the results of phase 3 SCORED and SOLOIST trials, which examined use of sotagliflozin in patients with type 2 diabetes.

November 16, 2020

Professor John McMurray explains why he is not as displeased as some colleagues are with the uptake of SGLT2 inhibitor prescribing rates for patients with heart failure or chronic kidney disease.

November 14, 2020

In honor of World Diabetes Day, we reached out to Lucia Novak, CRNP, to get her perspective on the role of nurses in the diabetes care model as "The Nurse and Diabetes" has been chosen as the official theme of this year's World Diabetes Day.

November 09, 2020

A nephrologist and professor from the University of Toronto offers insight into the results of a key kidney outcomes analysis of the VERTIS-CV trial.

October 26, 2020

The Assistant Dean of Community Engagement at the School of Nursing at the University of Pennsylvania offers perspective on addressing racial and ethnic disparities in medicine at an individual and societal level.

October 05, 2020

Muthiah Vaduganathan, MD, MPH, of Brigham and Women's discusses the barriers to preventing optimal prescribing practices for SGLT2 inhibitor and GLP-1 receptor agonist therapies.

September 28, 2020

An associate professor from University of Toronto discusses whose responsibility it is to prescribe SGLT2 inhibitors to patients.

September 11, 2020

An interview examining the use of coronary artery calcium scores for predicting CV events and stroke risk in real-world settings.

September 01, 2020

A look at the state of insulin affordability in 2020 and how the ongoing pandemic has impacted the situation.

August 17, 2020

A professor from Michigan Medicine discusses recent research from the institute and how protocols implemented at Michigan Medicine to manage the increased risk of severe outcomes associated with hyperglycemia in COVID-19.

August 04, 2020

A practicing endocrinologist and professor of medicine offers insight into the potential for increase in risk of blood clots in certain groups of women if they were to contract COVID-19.

November 10, 2017

Guidelines say metformin should be stopped where there is acute kidney injury or risk of renal compromise. Now there is evidence to support those recommendations.

May 17, 2017

Patients were randomized to standard care, nurse-led education intervention, or nurse-led education plus acceptance therapy.